Medical Director, Global Health (Translational Medicine)
14 hours ago
London
Historically, Novartis has supported sickle cell disease (SCD) care for over 50 years, developing chelators for iron overload management. Novartis BioMedical Research (BR) drives innovation across the company, focusing on new technologies for therapeutic breakthroughs. TM experts collaborate across